Something positive and of great importance also flowed through 2020: a handful of new and expanding business and service models at contract development and manufacturing organizations. CDMOs are changing, and providing drug sponsors – particularly virtual, and small to mid-sized organizations – with more, and it seems, improving options.
In this first of two parts, Outsourced Pharma Chief Editor Louis Garguilo presents what might be the trend of the year: the Best In Breed model. He next takes a look at what’s billed as “the biggest CDMO in the world.” He finishes up by introducing a trend some believe should have evolved years ago: universities teaming up with CDMOs and other industry players to offer new opportunities for “close to home” outsourcing.
You might also like: